Olaparib
| CAS No. | 763113-22-0 |
|---|---|
| MDL No. | MFCD13185161 |
| MF | C24H23FN4O3 |
| MW | 434.50 |
| InChI Key | FDLYAMZZIXQODN-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Olaparib is an N-acylpiperazine derived from the condensation of the carboxy group of 2-fluoro-5-[(4-oxo-3,4-dihydrophthalazin-1-yl)methyl]benzoic acid with the free amino group of N-cyclopropylcarbonyl piperazine. It is used to treat advanced ovarian cancer and functions as an antineoplastic agent, an EC 2.4.2.30 (NAD+ ADP-ribosyltransferase) inhibitor, and an apoptosis inducer. It belongs to the classes of cyclopropanes, monofluorobenzenes, and phthalazines.
| CAS No. | 763113-22-0 |
|---|---|
| Product Name | Olaparib |
Biological Targets
PARP1·PARP3·PARP2
Associated Conditions
squamous cell carcinoma·pancreatic neoplasm·triple-negative breast cancer·prostate adenocarcinoma·gastric cancer·
* The information provided here is compiled from public sources and is for reference only.
